Journey Medical Corporation (DERM) vs Organogenesis Holdings Inc. (ORGO)
A side-by-side comparison of Journey Medical Corporation and Organogenesis Holdings Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
DERM
Journey Medical Corporation
$6.32HealthcareDelayed quote: Oct 6, 2026, 2:05 PM EDT
ORGO
Organogenesis Holdings Inc.
$1.32HealthcareDelayed quote: Oct 6, 2026, 2:04 PM EDT
Total return — DERM vs ORGO
growth of $100 · dividends reinvested · last 5yDERM -29.6% (-6.8%/yr)ORGO -88.3% (-34.9%/yr)DERM compounded faster over this window
Log scale — wide-divergence pair
DERM ORGO
DERM vs ORGO: by the numbers
- •DERM is the larger company ($174M vs $170M market cap).
- •Both run net losses; DERM's is the smaller (-8.95% vs -19.76% net margin).
- •DERM grew revenue faster over the past five years (6.75% vs 1.05% CAGR).
Metrics side by side
Valuation
| Metric | DERM | ORGO |
|---|---|---|
| P/S ratio | 2.55 | 0.37 |
| P/B ratio | 5.41 | 1.15 |
| EV / EBITDA | 137.67 | 214.03 |
| FCF yield | N/A | 12.27% |
Profitability
| Metric | DERM | ORGO |
|---|---|---|
| Gross margin | 62.24% | 67.59% |
| Operating margin | -13.21% | 9.92% |
| Net margin | -8.95% | -19.76% |
| ROE | -19.01% | -31.32% |
| ROIC | -5.22% | -8.34% |
Growth (annualized)
| Metric | DERM | ORGO |
|---|---|---|
| Revenue CAGR (5Y) | 6.75% | 1.05% |
| FCF CAGR (5Y) | N/A | -5.54% |
| Total return CAGR (5Y) | N/A | -37.41% |
Frequently asked
- Which has grown faster, DERM or ORGO?
- Over the past five years, DERM grew revenue faster — DERM at a 6.75% CAGR versus ORGO at 1.05%.
Go deeper
Dig into the metrics
Journey Medical ROEOrganogenesis ROEJourney Medical operating marginOrganogenesis operating marginJourney Medical revenue growthOrganogenesis revenue growthJourney Medical free cash flowOrganogenesis free cash flow
Journey Medical & Organogenesis appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.